Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2024 Jan 16

PMID 38225780

Authors

Hye Young Hong

Youngmok Park

Seung Hyun Yong

Ala Woo

Ah Young Leem

Su Hwan Lee

Kyung Soo Chung

Sang Hoon Lee

Song Yee Kim

Eun Young Kim

Ji Ye Jung

Moo Suk Park

Young Sam Kim

Sung Jae Shin

Young Ae Kang

Affiliations

Soon will be listed here.

Abstract

Background: The treatment success rate for tuberculosis (TB) has stagnated at 80-81% in South Korea, indicating unsatisfactory outcomes. Enhancing treatment success rate necessitates the development of individualized treatment approaches for each patient. This study aimed to identify the risk factors associated with unfavorable treatment outcomes to facilitate tailored TB care.

Methods: We retrospectively analyzed the data of patients with active TB between January 2019 and December 2020 at a single tertiary referral center. We classified unfavorable treatment outcomes according to the 2021 World Health Organization guidelines as follows: "lost to follow-up" (LTFU), "not evaluated" (NE), "death," and "treatment failure" (TF). Moreover, we analyzed risk factors for each unfavorable outcome using Cox proportional hazard regression analysis.

Results: A total of 659 patients (median age 62 years; male 54.3%) were included in the study. The total unfavorable outcomes were 28.1%: 4.6% LTFU, 9.6% NE, 9.1% deaths, and 4.9% TF. Multivariate analysis showed that a culture-confirmed diagnosis of TB was associated with a lower risk of LTFU (adjusted hazard ratio [aHR], 0.25; 95% confidence interval [CI], 0.10-0.63), whereas the occurrence of adverse drug reactions (ADRs) significantly increased the risk of LTFU (aHR, 6.63; 95% CI, 2.63-16.69). Patients living far from the hospital (aHR, 4.47; 95% CI, 2.50-7.97) and those with chronic kidney disease (aHR, 3.21; 95% CI, 1.33-7.75) were at higher risk of being transferred out to other health institutions (NE). Higher mortality was associated with older age (aHR, 1.06; 95% CI, 1.04-1.09) and comorbidities. The ADRs that occurred during TB treatment were a risk factor for TF (aHR, 6.88; 95% CI, 2.24-21.13).

Conclusion: Unfavorable outcomes of patients with TB were substantial at a tertiary referral center, and the risk factors for each unfavorable outcome varied. To improve treatment outcomes, close monitoring and the provision of tailored care for patients with TB are necessary.

References

Oh A, Makmor-Bakry M, Islahudin F, Wong I . Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis. BMJ Glob Health. 2023; 8(1). PMC: 9853156. DOI: 10.1136/bmjgh-2022-010592. View

Alipanah N, Jarlsberg L, Miller C, Linh N, Falzon D, Jaramillo E . Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018; 15(7):e1002595. PMC: 6029765. DOI: 10.1371/journal.pmed.1002595. View

Gholami K, Kamali E, Hajiabdolbaghi M, Shalviri G . Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients. Pharm Pract (Granada). 2014; 4(3):134-8. PMC: 4156846. View

Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E . Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania. PLoS One. 2013; 7(12):e51828. PMC: 3526644. DOI: 10.1371/journal.pone.0051828. View

Karo B, Hauer B, Hollo V, van der Werf M, Fiebig L, Haas W . Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Euro Surveill. 2015; 20(49). DOI: 10.2807/1560-7917.ES.2015.20.49.30087. View

Jesus G, Pescarini J, Silva A, Torrens A, Carvalho W, Junior E . The effect of primary health care on tuberculosis in a nationwide cohort of 7·3 million Brazilian people: a quasi-experimental study. Lancet Glob Health. 2022; 10(3):e390-e397. PMC: 8847211. DOI: 10.1016/S2214-109X(21)00550-7. View

Caraux-Paz P, Diamantis S, de Wazieres B, Gallien S . Tuberculosis in the Elderly. J Clin Med. 2021; 10(24). PMC: 8703289. DOI: 10.3390/jcm10245888. View

Kim A, Cho S, Kim H, Jung H, Jo M, Lee J . Primary Care Patients' Preference for Hospitals over Clinics in Korea. Int J Environ Res Public Health. 2018; 15(6). PMC: 6025534. DOI: 10.3390/ijerph15061119. View

Sanchez-Padilla E, Marquer C, Kalon S, Qayyum S, Hayrapetyan A, Varaine F . Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study. Int J Tuberc Lung Dis. 2014; 18(2):160-7. DOI: 10.5588/ijtld.13.0369. View

10.

Myburgh H, Baloyi D, Loveday M, Meehan S, Osman M, Wademan D . A scoping review of patient-centred tuberculosis care interventions: Gaps and opportunities. PLOS Glob Public Health. 2023; 3(2):e0001357. PMC: 10021744. DOI: 10.1371/journal.pgph.0001357. View

11.

Linh N, Viney K, Gegia M, Falzon D, Glaziou P, Floyd K . World Health Organization treatment outcome definitions for tuberculosis: 2021 update. Eur Respir J. 2021; 58(2). DOI: 10.1183/13993003.00804-2021. View

12.

Mok J, An D, Kim S, Lee M, Kim C, Son H . Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014-2015. BMC Infect Dis. 2018; 18(1):655. PMC: 6293515. DOI: 10.1186/s12879-018-3574-y. View

13.

Rajagopalan S . Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001; 33(7):1034-9. DOI: 10.1086/322671. View

14.

Yu S, Sohn H, Kim H, Kim H, Oh K, Kim H . Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis. PLoS Med. 2021; 18(7):e1003717. PMC: 8318235. DOI: 10.1371/journal.pmed.1003717. View

15.

Kim H, Min J, Shin A, Koo H, Lim S, Park M . Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study. Int J Tuberc Lung Dis. 2020; 24(10):1016-1023. DOI: 10.5588/ijtld.19.0684. View

16.

Hase I, Gardner Toren K, Hirano H, Sakurai K, Horne D, Saito T . Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment Initiation. Drugs Aging. 2021; 38(9):807-815. PMC: 8256198. DOI: 10.1007/s40266-021-00880-4. View

17.

Tekle B, Mariam D, Ali A . Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002; 6(7):573-9. View

18.

Kim J, Yim J . Achievements in and Challenges of Tuberculosis Control in South Korea. Emerg Infect Dis. 2015; 21(11):1913-20. PMC: 4622233. DOI: 10.3201/eid2111.141894. View

19.

Kim H, Park S, Min J, Sun J, Shin A, Ha J . Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea. Sci Rep. 2022; 12(1):12362. PMC: 9300674. DOI: 10.1038/s41598-022-16441-7. View

20.

Min J, Kim H, Koo H, Ko Y, Oh J, Kim J . Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020. J Korean Med Sci. 2020; 35(43):e388. PMC: 7653169. DOI: 10.3346/jkms.2020.35.e388. View